ARIAD Announces FDA Clearance to Begin Clinical Development of AP32788
The Medicines Company Appoints Alexander J. Denner, Ph.D. to its Board of Directors
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2015 - Research and Markets
ARIAD Reports Inducement Grant to New Chief Executive Officer
ARIAD Announces Election of Alex Denner as Chairman of the Board of Directors
These two small-value funds have followed different paths to success in a difficult year for the peer group.